Treating OCD during COVID-19: Pharmacotherapy and combined treatments

 

Presented by Stephanie C. Eken, MD, FAAP, and Joshua Nadeau, PhD

View slides from this presentation

This presentation will provide a review of empirically supported pharmacological interventions for OCD and address some of the unique challenges of delivering this treatment both alone and in combination with CBT via telepsychiatry. 

Related resources

#
Treating co-occurring generalized anxiety disorder and depression: Expert tips to keep your clients from getting stuck
Learn about the most common dilemmas that arise when treating patients with…
Learn more
#
Workplace anxiety during a pandemic
In this webinar, participants will examine how worsened mental health has…
Learn more
#
Self-care and resilience: Practice what you teach
While healthcare professionals often encourage their patients to learn and…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.